Skip to main content
logo
4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
14.47
-0.24 (-1.63%)
Sep 25, 2026, 4:00 PM EDT - Market closed

4D Molecular Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
799429257866719705
Market Cap Growth
102.80%66.42%-70.27%20.40%2.03%-35.79%
Enterprise Value
40879-268562497478
Last Close Price
14.477.505.5720.2622.2121.94

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.695.036959.1441.80229.9339.09
PB Ratio
1.960.850.502.813.112.21
P/TBV Ratio
1.960.850.502.813.112.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.430.92-27.10158.8926.50

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.100.040.050.050.070.05
Net Debt / Equity Ratio
-0.96-0.97-0.94-0.92-0.87-0.94
Net Debt / EBITDA Ratio
2.073.252.632.621.884.28
Net Debt / FCF Ratio
2.514.493.483.622.063.82
Asset Turnover
0.190.1500.070.010.06
Quick Ratio
7.689.1514.5815.2113.5815.21
Current Ratio
8.039.3914.9215.6514.0215.69
Return on Equity (ROE)
-43.25%-27.57%-39.31%-37.41%-39.06%-24.79%
Return on Assets (ROA)
-25.09%-17.34%-26.08%-23.45%-22.35%-13.89%
Return on Capital Employed (ROCE)
-43.60%-29.90%-35.40%-35.20%-44.70%-21.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-22.41%-32.70%-62.48%-11.64%-14.94%-10.11%
FCF Yield
-19.51%-25.58%-53.74%-9.07%-13.65%-11.10%
Buyback Yield / Dilution
-15.93%-7.39%-37.86%-20.95%-16.66%-331.23%
SEC Filings: 10-K · 10-Q